arrow
L

Ligang Xing

Shandong Cancer Hospital and Institute
H指数:37
被引数:4,182

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Human Gallbladder Cancer Organoids

人胆囊癌类器官

2026-08-280
OAAI
Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH)

奥希替尼作为一线治疗在中国表皮生长因子受体突变阳性晚期非小细胞肺癌患者中的有效性和安全性:一项前瞻性、多中心、非干预性研究(FLOURISH)

2026-05-010
PRE
IGHG1+ Malignant Epithelial Cell-myCAF Crosstalk via MIF-CD74/APP-CD74 Drives Early Brain Metastasis in NSCLC: Delineated via Primary Tumor-Brain Metastasis Single-cell and Spatial Transcriptomics

IGHG1+恶性上皮细胞-myCAF串扰通过MIF-CD74/APP-CD74驱动NSCLC早期脑转移:通过原发肿瘤-脑转移单细胞和空间转录组学进行描绘

2026-03-230
PRE
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial

Glecirasib联合sitneprotafib在中国KRASG12C突变非小细胞肺癌患者中的疗效:一项开放标签、多中心、单臂、I/IIa期临床试验

2025-11-290
PRE
Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials

glecirasib在KRAS G12C突变实体瘤中的有效性和安全性:两项I/II期试验的合并分析

2025-10-020
OAAI
A PET/CT radiomics model for predicting distant metastasis in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study

PET/CT影像组学模型预测早期非小细胞肺癌患者立体定向放疗远处转移的多中心研究

2024-01-2210
OAAI